/iMATRIX-Atezo_Biomarker

Multimodal immunogenomic biomarker analysis of tumours from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab

Primary LanguageJupyter NotebookApache License 2.0Apache-2.0

Watchers